0 CHECKOUT

PRODUCT FILTERS

REGION

6
1
1
1

COUNTRY

1

CATEGORIES

  • 9
  • 7
  • 5
  • 5
  • 4
  • 4
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1

PRICE

6
8
28
41

PUBLISHED

2
3
22
41

PRODUCT TYPE

32
6
3

Search for: "ImmunoCellular Therapeutics, Ltd-Detailed Product Pipeline"

ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2015

ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2015 Summary This, ‘ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - 2015’, provides an overview of the ImmunoCellular Therapeutics,...

Published:  May 2015
Price:  From

ImmunoCellular Therapeutics, Ltd. (IMUC) - Financial and Strategic SWOT Analysis Review

ImmunoCellular Therapeutics, Ltd. (IMUC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

Published:  July 2016
Price:  From

ImmunoCellular Therapeutics, Ltd. (IMUC) - Product Pipeline Analysis

ImmunoCellular Therapeutics, Ltd. (IMUC) - Product Pipeline Analysis Summary ImmunoCellular Therapeutics, Ltd. (ImmunoCellular) is a clinical-stage biotechnology company. It undertakes the development...

Published:  May 2012
Price:  From

ImmunoCellular Therapeutics, Ltd. (IMUC) - Product Pipeline Analysis, 2013 Update

Summary ImmunoCellular Therapeutics, Ltd. (IMCU) is a clinical-stage biotechnology company. It develops immune-based therapies for the treatment of various cancers. The product pipeline of the company...

Published:  May 2013
Price:  From

ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - Q4 2010

ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “ImmunoCellular Therapeutics, Ltd. - Product Pipeline Review - Q4 2010”...

Published:  December 2010
Price:  From

CD19 Therapeutics Market, 2016 - 2030

The ‘CD19 Therapeutics Market, 2016-2030’ report provides a comprehensive analysis of the current market landscape and the future outlook of the growing pipeline of anti-CD19 therapeutics. The recent...

Published:  March 2016
Price:  From

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015 Summary The report ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015’, provides an overview of the...

Published:  December 2015
Price:  From

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015 Summary The report ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015’, provides an overview of the Recurrent Glioblastoma...

Published:  September 2015
Price:  From

Ovarian Cancer - Pipeline Review, H2 2015

Ovarian Cancer - Pipeline Review, H2 2015 Summary The report ‘Ovarian Cancer - Pipeline Review, H2 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  December 2015
Price:  From

Colon Cancer - Pipeline Review, H1 2015

Colon Cancer - Pipeline Review, H1 2015 Summary the, ‘Colon Cancer - Pipeline Review, H1 2015’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  June 2015
Price:  From

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015 Summary The report ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2015’, provides an overview of the Chronic Lymphocytic Leukemia...

Published:  December 2015
Price:  From

Follicular Lymphoma - Pipeline Review, H2 2015

Follicular Lymphoma - Pipeline Review, H2 2015 Summary The report ‘Follicular Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline. This report...

Published:  December 2015
Price:  From

Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015 Summary The report ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015’, provides an overview of the Glioblastoma Multiforme (GBM)’s...

Published:  December 2015
Price:  From

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

This report provides comprehensive information on the therapeutic development for Chronic Lymphocytic Leukemia (CLL), complete with comparative analysis at various stages, therapeutics assessment by...

Published:  June 2015
Price:  From

Follicular Lymphoma - Pipeline Review, H1 2015

Follicular Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Follicular Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline. This report...

Published:  June 2015
Price:  From

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015 Summary the, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Glioblastoma Multiforme (GBM)’s therapeutic...

Published:  June 2015
Price:  From

Ovarian Cancer - Pipeline Review, H1 2015

Ovarian Cancer - Pipeline Review, H1 2015 Summary the, ‘Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  June 2015
Price:  From

Epithelial Ovarian Cancer - Pipeline Review, H2 2015

Epithelial Ovarian Cancer - Pipeline Review, H2 2015 Summary The report ‘Epithelial Ovarian Cancer - Pipeline Review, H2 2015’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic...

Published:  October 2015
Price:  From

Mantle Cell Lymphoma - Pipeline Review, H2 2015

Mantle Cell Lymphoma - Pipeline Review, H2 2015 Summary The report ‘Mantle Cell Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline. This...

Published:  October 2015
Price:  From

Global & USA Cancer Immunotherapy Market Analysis to 2020 - Updated Edition

Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint...

Published:  July 2016
Price:  From
Loading Indicator

Our Clients

  • Goodyear Tire & Rubber Company
  • GlaxoSmithKline PLC
  • Hilton Worldwide
  • Hewlett-Packard Company
  • Accenture PLC
  • Qualcomm Incorporated
  • UBS AG